Answers are grounded in this paper and cite their sources.
Imaging, biochemical, and molecular studies indicate OA potential biomarkers in the IPFP related to inflammation, lipid dysregulation, and fibrosis. The combination of imaging and biochemical biomarkers could provide a better prediction of OA onset and the identification of OA progressors at an early stage. The IPFP study could also reveal potential therapeutic targets with the vision of better precision medicine.
No takes yet. Share an insight, caveat, or question.
Herrera et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: